Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex By: Benzinga via Benzinga May 23, 2022 at 09:57 AM EDT Catalyst Biosciences Inc(NASDAQ: CBIO) hasagreed to sellits portfolio of protease medicines that regulate ... Read More >> Related Stocks: Biogen Idec Catalyst Biosciences, Inc. - Common Stock Vertex Pharmaceuticals